Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H32N2O5 |
Molecular Weight | 368.4678 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12C[C@@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@]1([H])CCCC2)C(O)=O
InChI
InChIKey=IPVQLZZIHOAWMC-RFBLXINOSA-N
InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13-,14-,15+,16+/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
(2R,7AR)-2,7A-di-epi-Perindopril is an epimer (R, SR, SS) of the drug perindopril which is commonly used to treat high blood pressure, hypertension, heart failure, or stable coronary artery disease. This form of the drug is much less active.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4WR9JW8F9B
Created by
admin on Sat Dec 16 10:41:54 GMT 2023 , Edited by admin on Sat Dec 16 10:41:54 GMT 2023
|
PRIMARY | |||
|
72941692
Created by
admin on Sat Dec 16 10:41:54 GMT 2023 , Edited by admin on Sat Dec 16 10:41:54 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD